ObsEva (NASDAQ:OBSV) Now Covered by StockNews.com

StockNews.com started coverage on shares of ObsEva (NASDAQ:OBSV) in a research note issued to investors on Friday. The brokerage issued a hold rating on the stock.

ObsEva Stock Performance

The company has a market capitalization of $7.94 million, a price-to-earnings ratio of -0.11 and a beta of 0.68. The stock’s 50 day moving average price is $0.01. ObsEva has a one year low of $0.08 and a one year high of $2.14.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.